Non-infectivity of hepatitis B virus under nucleoside analog therapy revealed through auxiliary partial orthotopic liver transplantation

Non-infectivity of hepatitis B virus under nucleoside analog therapy revealed through auxiliary partial orthotopic liver transplantation

Saved in:

Bibliographic Details
Main Authors:	Xiaojie Chen, Guiwen Guan, Lin Wei, Jidong Jia, Xiangmei Chen, Fengmin Lu, Zhijun Zhu
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2025-07-01
Series:	Clinical and Molecular Hepatology
Subjects:	chronic hepatitis b liver transplantation nucleoside analog
Online Access:	http://e-cmh.org/upload/pdf/cmh-2025-0393.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Nucleoside Analog GS-441524 Effectively Attenuates the In Vitro Replication of Multiple Lineages of Circulating Canine Distemper Viruses Isolated from Wild North American Carnivores
by: Arturo Oliver-Guimera, et al.
Published: (2025-01-01)

6-Chlorocoumarin Conjugates with Nucleobases and Nucleosides as Potent Anti-Hepatitis C Virus Agents
by: Shu-Yu Lin, et al.
Published: (2025-04-01)

Efficacy and its Predictors of Antiviral Therapy with Nucleos(T)Ide Analogs in Patients with Chronic Hepatitis B
by: T. H. Nguyen, et al.
Published: (2024-04-01)

Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients treated with nucleotide analogs plus polyethylene glycol interferon
by: Yan Peng, et al.
Published: (2025-01-01)

Interferon therapy for chronic hepatitis B virus infection affects nucleoside metabolism: a metabolomics study
by: Xiangyang Ye, et al.
Published: (2025-07-01)

Synthesis of Some New Nucleoside Analogues Containing Seven Membered Ring and Studying Their Biological Activity
by: Baghdad Science Journal
Published: (2016-09-01)

Efficacy of nucleoside analogues for hepatitis B virus-related liver failure: A network meta-analysis
by: Wu Jian, et al.
Published: (2018-03-01)

Nucleoside/Nucleotide Analogues for the Treatment of Chronic Hepatitis B: A 3-Year Follow Up Study
by: Andri Sanityoso Sulaiman, et al.
Published: (2021-09-01)

Bacterial Purine Nucleoside Phosphorylases from Mesophilic and Thermophilic Sources: Characterization of Their Interaction with Natural Nucleosides and Modified Arabinofuranoside Analogues
by: Irina A. Bychek, et al.
Published: (2024-08-01)

Modern etiotropic therapy of chronic viral hepatitis B
by: E. B. Bun'kova, et al.
Published: (2024-10-01)

Unraveling resistance mechanisms to the novel nucleoside analog RX-3117 in lung cancer: insights into DNA repair, cell cycle dysregulation and targeting PKMYT1 for improved therapy
by: Mahrou Vahabi, et al.
Published: (2025-07-01)

Impact of nucleos(t)ide analogues on the risk of hepatocellular carcinoma in chronic hepatitis B patients: a time-dependent Cox regression analysis
by: Makoto Moriyama, et al.
Published: (2025-06-01)

Profile of Nucleotides and Nucleosides in Taiwanese Human Milk
by: Kuo-Yu Liao, et al.
Published: (2011-04-01)

Synthesis and Characterization of Some New Nucleoside Analogues from Substituted Benzimidazole via 1,3-Dipolar cycloaddition
by: Baghdad Science Journal
Published: (2016-06-01)

Longitudinal profile of plasma pregenomic RNA in patients with chronic hepatitis B infection on long-term nucleoside analogues and its interaction with clinical parameters
by: Lung-Yi Mak, et al.
Published: (2025-04-01)

nucleoside analogues for the treatment of influenza: history and experience
by: K. V. Kasianenko, et al.
Published: (2019-10-01)

The effectiveness of non-nucleoside dual therapy in “naive” HIV patients
by: Elena Veselova, et al.
Published: (2024-12-01)

Synthesis of New DltA Inhibitors and Their Application as Adjuvant Antibiotics to Re-Sensitize Methicillin-Resistant <i>Staphylococcus aureus</i>
by: David Leparfait, et al.
Published: (2025-06-01)

Cycloferon and Management of Herpes Virus Infection
by: L. M. Alimbarova
Published: (2020-05-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Modern modes of chronic hepatitis B treatment in daily clinical practice
by: M. V. Mayevskaya, et al.
Published: (2014-11-01)

Simultaneous determination of ten nucleosides and bases in Ganoderma by micellar electrokinetic chromatography
by: Feiya Sheng, et al.
Published: (2022-03-01)

Efficacy of antiviral therapy in the treatment of severe forms of acute hepatitis B
by: E. V. Esaulenko, et al.
Published: (2016-02-01)

Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
by: N. S. Shastina, et al.
Published: (2011-04-01)

Synthesis of 5-oxymethyl-1,2,4-triazole-3-carboxamides
by: L. E. Grebenkina, et al.
Published: (2022-09-01)

Transfusion of Blood Components during Orthotopic Hepatic Transplantation
by: S. V. Zhuravel, et al.
Published: (2007-08-01)

SELECTING THE MANAGEMENT OF PATIENTS WITH CHRONIC HEPATITIS B AFTER THE COMPLETION OF THE LONG-TERM ANTIVIRAL THERAPY
by: E. V. Esaulenko, et al.
Published: (2018-10-01)

Substituted benzylamino-2′-deoxyadenosine a modified nucleoside with radiosensitizing properties
by: Magdalena Datta, et al.
Published: (2025-05-01)

On the Quest for Biomarkers: A Comprehensive Analysis of Modified Nucleosides in Ovarian Cancer Cell Lines
by: Daniel A. Mohl, et al.
Published: (2025-04-01)

Enhancing the Yield of <i>Pleurotus ostreatus</i> Through the Addition of Nucleotides and Nucleosides
by: Chenmin Tang, et al.
Published: (2025-07-01)

Nucleoside Analogues for Chagas Disease and Leishmaniasis Therapy: Current Status and Future Perspectives
by: Emmanuel Awucha Nwoke, et al.
Published: (2024-11-01)

Circulating let‐7 Predicts Hepatic Fibrogenesis of 12‐Month Post‐Nucleos(t)ide Analog Treatment in Patients With Hepatitis B Virus
by: Yi‐Shan Tsai, et al.
Published: (2025-06-01)

Design, Synthesis, Characterization and antibacterial activity of new 1,2,3-triazole linked nucleosides
by: Aditya Aggarwal, et al.
Published: (2024-12-01)

Treatment response to nucleos(t)ide analogs in chronic hepatitis B with mildly elevated alanine aminotransferase: Letter to the editor on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
by: Jian Wang, et al.
Published: (2025-04-01)

Key Factors Influencing qHBsAg Dynamics in Chronic Hepatitis B Patients During Treatment with Direct Acting Antivirals
by: Mihai Daniel DODOT, et al.
Published: (2020-03-01)

Chronic hepatitis B and risk of kidney involvement
by: M. V. Mayevskaya, et al.
Published: (2013-05-01)

Development of Liposomal Forms of Modified Pyrimidine Nucleosides and Investigation of Their Antibacterial Properties
by: I. L. Karpenko, et al.
Published: (2020-05-01)

Spectrum of Non-Nucleoside Reverse Transcriptase Inhibitor-Associated Drug Resistance Mutations in Persons Living with HIV-1 Receiving Rilpivirine
by: Pavithra Nagarajan, et al.
Published: (2024-10-01)

Design, synthesis, and antitumor activity of novel thioheterocyclic nucleoside derivatives by suppressing the c-MYC pathway
by: Xian-Jia Li, et al.
Published: (2025-07-01)

APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
by: Tadeusz Robak
Published: (2010-05-01)